Epanutin 50mg Infatabs supply issue

Epanutin 50mg Infatabs supply issue

June 14, 2019

PSNC has become aware that the licensed Phenytoin 50mg Infatabs manufactured by Pfizer is currently unavailable. To meet patient need there are imported products available such as Dilantin Infatab (Canada).

Pharmacy teams that receive an NHS prescription for generic ‘Phenytoin 50mg chewable tablets or the brand ‘Epanutin Infatabs 50mg chewable tablets but unable to obtain and dispense any licensed stock should contact the prescriber for an alternativeIf the prescriber wishes to consider the unlicensed preparation, the prescription will need to be amended to read: Phenytoin 50mg chewable tablets (Special Order)’ or ‘Dilantin Infatabs 50mg chewable tablets (Imported (Canada))’.

Contractors will be reimbursed for what is ordered on the prescription. If the prescription indicates that it is for an unlicensed special for example ‘Phenytoin 50mg chewable tablets (Special Order), the contractor will be reimbursed for dispensing the unlicensed product. If the prescription does not indicate Special Order or similar, then the contractor will only be reimbursed the list price for the licensed product.  

A prescription calling for the unlicensed product should be endorsed as follows:  

  • Quantity dispensed 
  • Pack size 
  • Price per unit less any discount/rebate 
  • Manufacturer/importer MHRA license number 
  • Batch number 
  • Specials procurement fee endorsement of SP  

As a reminder, all prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission. 

See our factsheet for further guidance on endorsing unlicensed specials and imports. 

 



Posted in:


More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...